Dynamics of IgG-avidity and antibody levels after Covid-19
(2021) In Journal of Clinical Virology 144.- Abstract
Background: A potentially important aspect of the humoral immune response to Covid-19 is avidity, the overall binding strength between antibody and antigen. As low avidity is associated with a risk of re- infection in several viral infections, avidity might be of value to predict risk for reinfection with covid-19. Objectives: The purpose of this study was to describe the maturation of IgG avidity and the antibody-levels over time in patients with PCR-confirmed non-severe covid-19. Study design: Prospective longitudinal cohort study including patients with RT-PCR confirmed covid-19. Blood samples were drawn 1, 3 and 6 months after infection. Antibody levels and IgG-avidity were analysed. Results: The majority had detectable s- and... (More)
Background: A potentially important aspect of the humoral immune response to Covid-19 is avidity, the overall binding strength between antibody and antigen. As low avidity is associated with a risk of re- infection in several viral infections, avidity might be of value to predict risk for reinfection with covid-19. Objectives: The purpose of this study was to describe the maturation of IgG avidity and the antibody-levels over time in patients with PCR-confirmed non-severe covid-19. Study design: Prospective longitudinal cohort study including patients with RT-PCR confirmed covid-19. Blood samples were drawn 1, 3 and 6 months after infection. Antibody levels and IgG-avidity were analysed. Results: The majority had detectable s- and n-antibodies (88,1%, 89,1%, N = 75). The level of total n-antibodies significantly increased from 1 to 3 months (median value 28,3 vs 39,3 s/co, p<0.001) and significantly decreased from 3 to 6 months (median value 39,3 vs 17,1 s/co, p<0.001). A significant decrease in the IgG anti-spike levels (median value 37,6, 24,1 and 18,2 RU/ml, p<0.001) as well as a significant increase in the IgG-avidity index (median values 51,6, 66,0 and 71,0%, p<0.001) were seen from 1 to 3 to 6 months. Conclusion: We found a significant ongoing increase in avidity maturation after Covid-19 whilst the levels of antibodies were declining, suggesting a possible aspect of long-term immunity.
(Less)
- author
- Löfström, Emma LU ; Eringfält, Anna ; Kötz, Arne ; Wickbom, Fredrik LU ; Tham, Johan LU ; Lingman, Markus ; Nygren, Jens M. LU and Undén, Johan LU
- organization
- publishing date
- 2021-11-01
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Anti-nucleocapsid, Anti-spike, Antibody, Avidity, Covid-19, SARS-CoV-2
- in
- Journal of Clinical Virology
- volume
- 144
- article number
- 104986
- publisher
- Elsevier
- external identifiers
-
- scopus:85115659440
- pmid:34563862
- ISSN
- 1386-6532
- DOI
- 10.1016/j.jcv.2021.104986
- language
- English
- LU publication?
- yes
- additional info
- Publisher Copyright: © 2021
- id
- 41c974be-c425-4c41-90c9-67bd9c597a09
- date added to LUP
- 2021-11-19 13:56:26
- date last changed
- 2024-04-20 15:40:56
@article{41c974be-c425-4c41-90c9-67bd9c597a09, abstract = {{<p>Background: A potentially important aspect of the humoral immune response to Covid-19 is avidity, the overall binding strength between antibody and antigen. As low avidity is associated with a risk of re- infection in several viral infections, avidity might be of value to predict risk for reinfection with covid-19. Objectives: The purpose of this study was to describe the maturation of IgG avidity and the antibody-levels over time in patients with PCR-confirmed non-severe covid-19. Study design: Prospective longitudinal cohort study including patients with RT-PCR confirmed covid-19. Blood samples were drawn 1, 3 and 6 months after infection. Antibody levels and IgG-avidity were analysed. Results: The majority had detectable s- and n-antibodies (88,1%, 89,1%, N = 75). The level of total n-antibodies significantly increased from 1 to 3 months (median value 28,3 vs 39,3 s/co, p<0.001) and significantly decreased from 3 to 6 months (median value 39,3 vs 17,1 s/co, p<0.001). A significant decrease in the IgG anti-spike levels (median value 37,6, 24,1 and 18,2 RU/ml, p<0.001) as well as a significant increase in the IgG-avidity index (median values 51,6, 66,0 and 71,0%, p<0.001) were seen from 1 to 3 to 6 months. Conclusion: We found a significant ongoing increase in avidity maturation after Covid-19 whilst the levels of antibodies were declining, suggesting a possible aspect of long-term immunity.</p>}}, author = {{Löfström, Emma and Eringfält, Anna and Kötz, Arne and Wickbom, Fredrik and Tham, Johan and Lingman, Markus and Nygren, Jens M. and Undén, Johan}}, issn = {{1386-6532}}, keywords = {{Anti-nucleocapsid; Anti-spike; Antibody; Avidity; Covid-19; SARS-CoV-2}}, language = {{eng}}, month = {{11}}, publisher = {{Elsevier}}, series = {{Journal of Clinical Virology}}, title = {{Dynamics of IgG-avidity and antibody levels after Covid-19}}, url = {{http://dx.doi.org/10.1016/j.jcv.2021.104986}}, doi = {{10.1016/j.jcv.2021.104986}}, volume = {{144}}, year = {{2021}}, }